Difference between revisions of "Template:Estrogen receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
|||
| (241 intermediate revisions by 18 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name = | + | | name = Estrogen receptor modulators |
| − | | title = [[Estrogen]] | + | | title = [[Estrogen receptor]] [[receptor modulator|modulator]]s |
| − | | | + | | bodyclass = hlist |
| state = {{{state<includeonly>|collapsed</includeonly>}}} | | state = {{{state<includeonly>|collapsed</includeonly>}}} | ||
| − | | groupstyle = text-align:center; | + | | groupstyle = text-align:center; |
| − | | group1 = | + | | group1 = {{abbrlink|ER|Estrogen receptor}} |
| − | | | + | | list1 = {{Navbox|subgroup |
| − | | groupstyle = text-align:center; | + | | groupstyle = text-align:center |
| + | | groupwidth = 6em; | ||
| − | | group1 = | + | | group1 = Agonists |
| − | | list1 | + | | list1 = |
| − | + | * ''Steroidal:'' [[2-Hydroxyestradiol]] | |
| − | + | * [[2-Hydroxyestrone]] | |
| − | + | * [[3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol]] | |
| − | |||
| − | |||
| − | * [[ | ||
| − | * [[ | ||
| − | |||
| − | |||
* [[3α-Androstanediol]] | * [[3α-Androstanediol]] | ||
| − | * [[3β- | + | * [[3α,5α-Dihydrolevonorgestrel]] |
| + | * [[3β,5α-Dihydrolevonorgestrel]] | ||
* [[3α-Hydroxytibolone]] | * [[3α-Hydroxytibolone]] | ||
* [[3β-Hydroxytibolone]] | * [[3β-Hydroxytibolone]] | ||
| − | * [[7-Oxo-DHEA]] | + | * [[3β-Androstanediol]] |
| + | * [[4-Androstenediol]] | ||
| + | * [[4-Androstenedione]] | ||
| + | * [[4-Fluoroestradiol]] | ||
| + | * [[4-Hydroxyestradiol]] | ||
| + | * [[4-Hydroxyestrone]] | ||
| + | * [[4-Methoxyestradiol]] | ||
| + | * [[4-Methoxyestrone]] | ||
| + | * [[5-Androstenediol]] | ||
| + | * [[7-Keto-DHEA|7-Oxo-DHEA]] | ||
* [[7α-Hydroxy-DHEA]] | * [[7α-Hydroxy-DHEA]] | ||
| + | * [[7α-Methylestradiol]] | ||
* [[7β-Hydroxyepiandrosterone]] | * [[7β-Hydroxyepiandrosterone]] | ||
| − | * [[8β-VE2| | + | * [[8,9-Dehydroestradiol]] |
| − | * [[16- | + | * [[8,9-Dehydroestrone]] |
| + | * [[8β-VE2]] | ||
| + | * [[10β,17β-Dihydroxyestra-1,4-dien-3-one|10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)]] | ||
| + | * [[11β-Chloromethylestradiol]] | ||
| + | * [[11β-Methoxyestradiol]] | ||
| + | * [[15α-Hydroxyestradiol]] | ||
| + | * [[16-Ketoestradiol]] | ||
| + | * [[16-Ketoestrone]] | ||
| + | * [[16α-Fluoroestradiol]] | ||
| + | * [[16α-Hydroxy-DHEA]] | ||
* [[16α-Hydroxyestrone]] | * [[16α-Hydroxyestrone]] | ||
| − | * [[16α- | + | * [[16α-Iodoestradiol]] |
| − | * [[16α-LE2 | + | * [[16α-LE2]] |
| − | * [[ | + | * [[16β-Hydroxyestrone]] |
| − | * [[ | + | * [[16β,17α-Epiestriol|16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)]] |
| − | * [[ | + | * [[17α-Estradiol]] ([[alfatradiol]]) |
| − | * [[ | + | * [[17α-Dihydroequilenin]] |
| + | * [[17α-Dihydroequilin]] | ||
| + | * [[17α-Epiestriol|17α-Epiestriol (16α-hydroxy-17α-estradiol)]] | ||
| + | * [[17α-Ethynyl-3α-androstanediol]] | ||
| + | * [[17α-Ethynyl-3β-androstanediol]] | ||
| + | * [[17β-Dihydroequilenin]] | ||
| + | * [[17β-Dihydroequilin]] | ||
| + | * [[17β-Methyl-17α-dihydroequilenin]] | ||
| + | * [[Abiraterone]] | ||
| + | * [[Abiraterone acetate]] | ||
* [[Alestramustine]] | * [[Alestramustine]] | ||
* [[Almestrone]] | * [[Almestrone]] | ||
| − | * [[Anabolic steroid]]s ([[ | + | * [[Anabolic steroid]]s (e.g., [[testosterone]] and [[List of androgen esters#Testosterone esters|ester]]s, [[methyltestosterone]], [[metandienone|metandienone (methandrostenolone)]], [[nandrolone]] and [[List of androgen esters#Nandrolone esters|ester]]s, many others; via estrogenic metabolites) |
| − | |||
| − | |||
* [[Atrimustine]] | * [[Atrimustine]] | ||
| − | * [[ | + | * [[Bolandiol]] |
| − | * [[ | + | * [[Bolandiol dipropionate]] |
| − | * [[ | + | * [[Butolame]] |
| − | * [[ | + | * [[Clomestrone]] |
| − | |||
* [[Cloxestradiol]] | * [[Cloxestradiol]] | ||
| − | * [[ | + | ** [[Cloxestradiol acetate]] |
| − | * [[ | + | * [[Conjugated estriol]] |
| − | * [[ | + | * [[Conjugated estrogens]] |
| + | * [[Cyclodiol]] | ||
| + | * [[Cyclotriol]] | ||
* [[Dehydroepiandrosterone|DHEA]] | * [[Dehydroepiandrosterone|DHEA]] | ||
* [[Dehydroepiandrosterone|DHEA-S]] | * [[Dehydroepiandrosterone|DHEA-S]] | ||
| − | * [[ | + | * [[ent-Estradiol|''ent''-Estradiol]] |
| − | * [[ | + | * [[Epiestriol|Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Epimestrol]] | * [[Epimestrol]] | ||
| − | * [[ | + | * [[Equilenin]] |
| − | * [[ | + | * [[Equilin]] |
| + | * [[ERA-63|ERA-63 (ORG-37663)]] | ||
| + | * [[Esterified estrogens]] | ||
* [[Estetrol]] | * [[Estetrol]] | ||
| − | * [[Estradiol | + | * [[Estradiol]] |
| − | * | + | ** [[List of estrogen esters#Estradiol esters|Estradiol esters]] |
| − | + | ** [[Lipoidal estradiol]] | |
| − | + | ** [[Polyestradiol phosphate]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | * [[Estradiol | ||
| − | |||
| − | * | ||
| − | * [[ | ||
| − | * | ||
| − | * [[ | ||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Estramustine]] | * [[Estramustine]] | ||
* [[Estramustine phosphate]] | * [[Estramustine phosphate]] | ||
| Line 98: | Line 94: | ||
* [[Estrazinol]] | * [[Estrazinol]] | ||
* [[Estriol]] | * [[Estriol]] | ||
| − | * [[Estriol | + | ** [[List of estrogen esters#Estriol esters|Estriol esters]] |
| − | * [[ | + | ** [[Polyestriol phosphate]] |
* [[Estrofurate]] | * [[Estrofurate]] | ||
| + | * [[Estrogenic substances]] | ||
* [[Estromustine]] | * [[Estromustine]] | ||
* [[Estrone]] | * [[Estrone]] | ||
| − | * [[Estrone | + | ** [[List of estrogen esters#Estrone esters|Estrone esters]] |
| − | * | + | ** [[Estrone methyl ether]] |
| − | * [[Estrone | + | ** [[Estropipate]] |
| − | * | ||
| − | * [[Estropipate | ||
| − | |||
* [[Etamestrol|Etamestrol (eptamestrol)]] | * [[Etamestrol|Etamestrol (eptamestrol)]] | ||
| − | * [[ | + | * [[Ethinylandrostenediol]] |
| − | * [[ | + | ** [[Ethandrostate]] |
| + | * [[Ethinylestradiol]] | ||
| + | ** [[Ethinylestradiol 3-benzoate]] | ||
| + | ** [[Ethinylestradiol sulfonate]] | ||
| + | * [[Ethinylestriol]] | ||
| + | * [[Ethylestradiol]] | ||
| + | * [[Etynodiol]] | ||
* [[Etynodiol diacetate]] | * [[Etynodiol diacetate]] | ||
| − | * [[ | + | * [[Hexolame]] |
| − | * [[ | + | * [[Hippulin]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Hydroxyestrone diacetate]] | * [[Hydroxyestrone diacetate]] | ||
| − | * [[ | + | * [[Lynestrenol]] |
| − | * [[ | + | * [[Lynestrenol phenylpropionate]] |
* [[Mestranol]] | * [[Mestranol]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Methylestradiol]] | * [[Methylestradiol]] | ||
| − | |||
* [[Moxestrol]] | * [[Moxestrol]] | ||
| + | * [[Mytatrienediol]] | ||
* [[Nilestriol]] | * [[Nilestriol]] | ||
| + | * [[Norethisterone]] | ||
* [[Noretynodrel]] | * [[Noretynodrel]] | ||
* [[Orestrate]] | * [[Orestrate]] | ||
| + | * [[Pentolame]] | ||
| + | * [[Prodiame]] | ||
| + | * [[Prolame]] | ||
| + | * [[Promestriene]] | ||
| + | * [[RU-16117]] | ||
| + | * [[Quinestradol]] | ||
| + | * [[Quinestrol]] | ||
| + | * [[Tibolone]] | ||
| + | |||
| + | * ''Nonsteroidal:'' [[(R,R)-Tetrahydrochrysene|(R,R)-THC]] | ||
| + | * [[(S,S)-Tetrahydrochrysene|(S,S)-THC]] | ||
| + | * [[2,8-Dihydroxyhexahydrochrysene|2,8-DHHHC]] | ||
| + | * [[β-LGND1]] | ||
| + | * [[β-LGND2|β-LGND2 (GTx-878)]] | ||
| + | * [[AC-186]] | ||
| + | * [[Allenestrol]] | ||
| + | * [[Allenolic acid]] | ||
| + | * [[Benzestrol]] | ||
| + | * [[Bifluranol]] | ||
| + | * [[Bisdehydrodoisynolic acid]] | ||
| + | * [[Butestrol]] | ||
| + | * [[Carbestrol]] | ||
| + | * [[D-15414]] | ||
| + | * [[DCW234]] | ||
| + | * [[Diarylpropionitrile]] | ||
| + | * [[Dienestrol]] | ||
| + | ** [[Dienestrol diacetate]] | ||
| + | * [[Diethylstilbestrol]] | ||
| + | ** [[List of estrogen esters#Diethylstilbestrol esters|Diethylstilbestrol esters]] | ||
| + | * [[Dimestrol|Dimestrol (dianisylhexene)]] | ||
| + | * [[Dimethylstilbestrol]] | ||
| + | * [[Doisynoestrol|Doisynoestrol (fenocycline)]] | ||
| + | * [[Doisynolic acid]] | ||
| + | * [[Efavirenz]] | ||
| + | * [[ERB-196|ERB-196 (WAY-202196)]] | ||
| + | * [[Erteberel|Erteberel (SERBA-1, LY-500307)]] | ||
| + | * [[Estrobin|Estrobin (DBE)]] | ||
| + | * [[Fenestrel]] | ||
| + | * [[FERb 033]] | ||
| + | * [[Fosfestrol|Fosfestrol (diethylstilbestrol diphosphate)]] | ||
| + | * [[Furostilbestrol|Furostilbestrol (diethylstilbestrol difuroate)]] | ||
| + | * [[GTx-758]] | ||
| + | * [[Hexestrol]] | ||
| + | ** [[List of estrogen esters#Hexestrol esters|Hexestrol esters]] | ||
| + | * [[ICI-85966|ICI-85966 (Stilbostat)]] | ||
| + | * [[M2613]] | ||
| + | * [[meso-Butestrol|''meso''-Butestrol]] | ||
| + | * [[meso-Hexestrol|''meso''-Hexestrol]] | ||
| + | * [[Mestilbol]] | ||
| + | * [[Methallenestril]] | ||
| + | * [[Methestrol]] | ||
| + | * [[Methestrol dipropionate]] | ||
* [[Paroxypropione]] | * [[Paroxypropione]] | ||
| − | * [[ | + | * [[Pentafluranol]] |
| − | * [[ | + | * [[Phenestrol]] |
* [[Prinaberel|Prinaberel (ERB-041, WAY-202041)]] | * [[Prinaberel|Prinaberel (ERB-041, WAY-202041)]] | ||
* [[Propylpyrazoletriol]] | * [[Propylpyrazoletriol]] | ||
| − | |||
| − | |||
* [[Quadrosilan]] | * [[Quadrosilan]] | ||
| − | * [[ | + | * [[SC-3296]] |
| − | * [[ | + | * [[SC-4289]] |
| + | * [[SERBA-2]] | ||
* [[SKF-82,958]] | * [[SKF-82,958]] | ||
| − | * [[Stilbenoid]]s (e.g., [[resveratrol]]) | + | * [[Terfluranol]] |
| + | * [[Triphenylbromoethylene]] | ||
| + | * [[Triphenylchloroethylene]] | ||
| + | * [[Triphenyliodoethylene]] | ||
| + | * [[Triphenylmethylethylene|Triphenylmethylethylene (triphenylpropene)]] | ||
| + | * [[WAY-166818]] | ||
| + | * [[WAY-169916]] | ||
| + | * [[WAY-200070]] | ||
| + | * [[WAY-204688|WAY-204688 (SIM-688)]] | ||
| + | * [[WAY-214156]] | ||
| + | |||
| + | * ''Unknown/unsorted:'' [[ERB-26]]<!--Selective ERβ agonist; active enantiomer of ERB-79--> | ||
| + | * [[ERA-45]]<!--Selective ERα agonist--> | ||
| + | * [[ERB-79]]<!--Selective ERβ agonist--> | ||
| + | * [[ZK-283197]]<!--Selective ERβ agonist--> | ||
| + | |||
| + | * ''Xenoestrogens:'' [[Anise]]-related (e.g., [[anethole]], [[anol]], [[dianethole]], [[dianol]], [[photoanethole]]) | ||
| + | * [[Chalconoid]]s (e.g., [[isoliquiritigenin]], [[phloretin]], [[phlorizin|phlorizin (phloridzin)]], [[wedelolactone]]) | ||
| + | * [[Coumestan]]s (e.g., [[coumestrol]], [[psoralidin]]) | ||
| + | * [[Flavonoid]]s (incl. [[7,8-Dihydroxyflavone|7,8-DHF]], [[8-Prenylnaringenin|8-prenylnaringenin]], [[apigenin]], [[baicalein]], [[baicalin]], [[biochanin A]], [[calycosin]], [[catechin]], [[daidzein]], [[daidzin]], [[epicatechin gallate|ECG]], [[epigallocatechin gallate|EGCG]], [[epicatechin]], [[equol]], [[formononetin]], [[glabrene]], [[glabridin]], [[genistein]], [[genistin]], [[glycitein]], [[kaempferol]], [[liquiritigenin]], [[mirificin]], [[myricetin]], [[naringenin]], [[penduletin]], [[pinocembrin]], [[prunetin]], [[puerarin]], [[quercetin]], [[tectoridin]], [[tectorigenin]]) | ||
| + | * [[Lavender oil]] | ||
| + | * [[Lignan]]s (e.g., [[enterodiol]], [[enterolactone]], [[nyasol|nyasol (''cis''-hinokiresinol)]]) | ||
| + | * [[Metalloestrogen]]s (e.g., [[cadmium]]) | ||
| + | * [[Pesticide]]s (e.g., [[alternariol]], [[dieldrin]], [[endosulfan]], [[fenarimol]], [[HPTE]], [[methiocarb]], [[methoxychlor]], [[triclocarban]], [[triclosan]]) | ||
| + | * [[Phytosteroid]]s (e.g., [[digitoxin]] ([[digitalis]]), [[diosgenin]], [[guggulsterone]]) | ||
| + | * [[Phytosterol]]s (e.g., [[β-sitosterol]], [[campesterol]], [[stigmasterol]]) | ||
| + | * [[Resorcylic acid lactone]]s (e.g., [[zearalanone]], [[α-zearalenol]], [[β-zearalenol]], [[zearalenone]], [[zeranol|zeranol (α-zearalanol)]], [[taleranol|taleranol (teranol, β-zearalanol)]]) | ||
| + | * [[Steroid]]-like (e.g., [[deoxymiroestrol]], [[miroestrol]]) | ||
| + | * [[Stilbenoid]]s (e.g., [[resveratrol]], [[rhaponticin]]) | ||
* [[Synthetic xenoestrogen]]s (e.g., [[alkylphenol]]s, [[bisphenol]]s (e.g., [[bisphenol A|BPA]], [[bisphenol F|BPF]], [[bisphenol S|BPS]]), [[dichlorodiphenyltrichloroethane|DDT]], [[paraben]]s, [[polybrominated biphenyl|PBBs]], [[4-hydroxybenzoic acid|PHBA]], [[phthalate]]s, [[polychlorinated biphenyl|PCBs]]) | * [[Synthetic xenoestrogen]]s (e.g., [[alkylphenol]]s, [[bisphenol]]s (e.g., [[bisphenol A|BPA]], [[bisphenol F|BPF]], [[bisphenol S|BPS]]), [[dichlorodiphenyltrichloroethane|DDT]], [[paraben]]s, [[polybrominated biphenyl|PBBs]], [[4-hydroxybenzoic acid|PHBA]], [[phthalate]]s, [[polychlorinated biphenyl|PCBs]]) | ||
| − | * [[ | + | * Others (e.g., [[agnuside]], [[rotundifuran]]) |
| − | |||
| − | + | | group2 = Mixed<br />({{abbrlink|SERMs|Selective estrogen receptor modulators}}) | |
| − | + | | list2 = | |
| − | * [[2- | + | * [[2-Phenylbenzofuran]] |
| + | * [[2-Phenylbenzothiophene]] | ||
| + | * [[4'-Hydroxynorendoxifen]] | ||
* [[27-Hydroxycholesterol]] | * [[27-Hydroxycholesterol]] | ||
| + | * [[Acefluranol]] | ||
* [[Acolbifene]] | * [[Acolbifene]] | ||
* [[Afimoxifene]] | * [[Afimoxifene]] | ||
| + | * [[Anordiol]] | ||
* [[Anordrin]] | * [[Anordrin]] | ||
| − | |||
* [[Arzoxifene]] | * [[Arzoxifene]] | ||
* [[Bazedoxifene]] | * [[Bazedoxifene]] | ||
| + | * [[Brilanestrant]] | ||
* [[Broparestrol]] | * [[Broparestrol]] | ||
* [[Chlorotrianisene]] | * [[Chlorotrianisene]] | ||
* [[Clomifene]] | * [[Clomifene]] | ||
* [[Clomifenoxide]] | * [[Clomifenoxide]] | ||
| + | * [[CN-55945-27]] | ||
* [[Cyclofenil]] | * [[Cyclofenil]] | ||
| + | * [[D-15413]] | ||
| + | * [[Desmethylchlorotrianisene]] | ||
* [[Droloxifene]] | * [[Droloxifene]] | ||
| + | * [[Elacestrant]] | ||
* [[Enclomifene]] | * [[Enclomifene]] | ||
* [[Endoxifen]] | * [[Endoxifen]] | ||
| + | * [[Etacstil|Etacstil (GW-5638, DPC-974)]] | ||
* [[Ethamoxytriphetol|Ethamoxytriphetol (MER-25)]] | * [[Ethamoxytriphetol|Ethamoxytriphetol (MER-25)]] | ||
* [[Femarelle]] | * [[Femarelle]] | ||
* [[Fispemifene]] | * [[Fispemifene]] | ||
| − | * [[ | + | * [[GW-7604]] |
| + | * [[ICI-55548]]<!--N--desmethyltamoxifen--> | ||
* [[Idoxifene]] | * [[Idoxifene]] | ||
* [[Lasofoxifene]] | * [[Lasofoxifene]] | ||
* [[Levormeloxifene]] | * [[Levormeloxifene]] | ||
| + | * [[LN-1643]] | ||
| + | * [[LN-2299]] | ||
| + | * [[LY-117018]]<!--63676-25-5; benzothiophene derivative--> | ||
* [[Menerba]] | * [[Menerba]] | ||
| − | |||
* [[Miproxifene]] | * [[Miproxifene]] | ||
| + | * [[Miproxifene phosphate]] | ||
| + | * [[MRL-37]] | ||
* [[Nafoxidine]] | * [[Nafoxidine]] | ||
* [[Nitromifene]] | * [[Nitromifene]] | ||
| + | * [[NNC 45-0095]] | ||
| + | * [[NNC 45-0320]] | ||
| + | * [[NNC 45-0781]] | ||
| + | * [[NNC 45-1506]] | ||
* [[Ormeloxifene]] | * [[Ormeloxifene]] | ||
* [[Ospemifene]] | * [[Ospemifene]] | ||
* [[Panomifene]] | * [[Panomifene]] | ||
| − | |||
* [[Pipendoxifene]] | * [[Pipendoxifene]] | ||
| + | * [[Promensil]] | ||
* [[Raloxifene]] | * [[Raloxifene]] | ||
| − | * [[2E-3-(4-((Z)-4-Chloro-1,2-diphenylbut-1-enyl)phenyl)acrylic acid | + | * [[Rimostil|Rimostil (P-081)]] |
| − | + | * [[Spironolactone]] | |
| + | * [[SS1010]]<!--2E-3-(4-((Z)-4-Chloro-1,2-diphenylbut-1-enyl)phenyl)acrylic acid--> | ||
* [[Tamoxifen]] | * [[Tamoxifen]] | ||
| − | * [[ | + | * [[TAS-108|TAS-108 (SR-16234)]] |
| − | |||
| − | |||
* [[Toremifene]] | * [[Toremifene]] | ||
* [[Trioxifene]] | * [[Trioxifene]] | ||
| − | * [[(6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)-(4-(4-(1-methylethyl)-1-piperazinyl)phenyl)methanone | + | * [[TZE-5323]] |
| + | * [[U-11555A]] | ||
| + | * [[U-11634]] | ||
| + | * [[Y-134]]<!--(6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)-(4-(4-(1-methylethyl)-1-piperazinyl)phenyl)methanone--> | ||
* [[Zindoxifene]] | * [[Zindoxifene]] | ||
* [[Zuclomifene]] | * [[Zuclomifene]] | ||
| − | + | | group3 = Antagonists | |
| − | + | | list3 = | |
* [[(R,R)-Tetrahydrochrysene|(R,R)-THC]] | * [[(R,R)-Tetrahydrochrysene|(R,R)-THC]] | ||
| − | * [[Fulvestrant]] | + | * [[7β-Hydroxy-DHEA]] |
| + | * [[Chloroindazole]] | ||
| + | * [[Cytestrol acetate]] | ||
| + | * [[EM-800|EM-800 (SCH-57050)]] | ||
| + | * [[Epitiostanol]] | ||
| + | * [[ERA-90]]<!--Selective ERα antagonist--> | ||
| + | * [[ERB-88]]<!--Selective ERβ antagonist--> | ||
| + | * [[Fulvestrant|Fulvestrant (ICI-182780)]] | ||
| + | * [[Glyceollin]]s ([[Glyceollin I|I]], [[Glyceollin II|II]], [[Glyceollin III|III]], [[Glyceollin IV|IV]]) | ||
* [[ICI-164384]] | * [[ICI-164384]] | ||
| + | * [[MDL-101906]] | ||
| + | * [[Mepitiostane]] | ||
| + | * [[Methylepitiostanol]] | ||
* [[Methylpiperidinopyrazole]] | * [[Methylpiperidinopyrazole]] | ||
* [[MIBE]] | * [[MIBE]] | ||
| + | * [[Oxabicycloheptene sulfonate]] | ||
| + | * [[Phenytoin]] | ||
* [[PHTPP]] | * [[PHTPP]] | ||
* [[Prochloraz]] | * [[Prochloraz]] | ||
| + | * [[RU-39411]] | ||
* [[RU-58668]] | * [[RU-58668]] | ||
* [[SS1020]] | * [[SS1020]] | ||
| − | * [[ | + | * [[TAS-108|TAS-108 (SR-16234)]] |
| + | * [[ZB716]]<!--Fulvestrant-3 boronic acid--> | ||
* [[ZK-164015]] | * [[ZK-164015]] | ||
* [[ZK-191703]] | * [[ZK-191703]] | ||
| − | + | * ''Coregulator-binding modulators:'' [[ERX-11]] | |
| − | + | * ''Noncompetitive inhibitors:'' [[Trilostane]] | |
| − | |||
| − | |||
| − | + | }} | |
| − | + | ||
| + | | group2 = {{abbrlink|GPER|G protein-coupled estrogen receptor}} | ||
| + | | list2 = {{Navbox|subgroup | ||
| + | | groupstyle = text-align:center | ||
| + | | groupwidth = 6em; | ||
| + | |||
| + | | group1 = Agonists | ||
| + | | list1 = | ||
| + | * [[2-Methoxyestradiol]] | ||
* [[7β-Hydroxyepiandrosterone]] | * [[7β-Hydroxyepiandrosterone]] | ||
* [[Afimoxifene|Afimoxifene (4-hydroxytamoxifen)]] | * [[Afimoxifene|Afimoxifene (4-hydroxytamoxifen)]] | ||
| + | * [[Aldosterone]] | ||
* [[Atrazine]] | * [[Atrazine]] | ||
* [[Bisphenol A]] | * [[Bisphenol A]] | ||
* [[Daidzein]] | * [[Daidzein]] | ||
* [[DDT]] ([[p,p'-DDT]], [[o',p'-DDE]]) | * [[DDT]] ([[p,p'-DDT]], [[o',p'-DDE]]) | ||
| + | * [[Diarylpropionitrile]] | ||
* [[Equol]] | * [[Equol]] | ||
* [[Estradiol]] | * [[Estradiol]] | ||
| − | * [[Fulvestrant|Fulvestrant (ICI- | + | * [[Ethinylestradiol]] |
| + | * [[Fulvestrant|Fulvestrant (ICI-182780)]] | ||
* [[G-1 (drug)|G-1]] | * [[G-1 (drug)|G-1]] | ||
* [[Genistein]] | * [[Genistein]] | ||
| Line 246: | Line 354: | ||
* [[Nonylphenol]] | * [[Nonylphenol]] | ||
* [[Oleuropein]] | * [[Oleuropein]] | ||
| − | * [[Polychlorinated biphenyl|PCB]] ([[2,2',5'-PCB-4-OH]]) | + | * [[Polychlorinated biphenyl|PCB]]s ([[2,2',5'-PCB-4-OH]]) |
* [[Propylpyrazoletriol]] | * [[Propylpyrazoletriol]] | ||
* [[Quercetin]] | * [[Quercetin]] | ||
* [[Raloxifene]] | * [[Raloxifene]] | ||
* [[Resveratrol]] | * [[Resveratrol]] | ||
| + | * [[STX (drug)|STX]] | ||
* [[Tamoxifen]] | * [[Tamoxifen]] | ||
* [[Tectoridin]] | * [[Tectoridin]] | ||
| − | |||
| − | + | | group2 = Antagonists | |
| − | + | | list2 = | |
| + | * [[CCL18]] | ||
* [[Estriol]] | * [[Estriol]] | ||
* [[G-15 (drug)|G-15]] | * [[G-15 (drug)|G-15]] | ||
| Line 262: | Line 371: | ||
* [[MIBE]] | * [[MIBE]] | ||
| − | + | | group3 = Unknown | |
| + | | list3 = | ||
| + | * [[Diethylstilbestrol]] | ||
| + | * [[Zearalenone]] | ||
| + | |||
}} | }} | ||
| − | | | + | <!-- |
| − | | | + | | group3 = {{abbrlink|ER-X|Estrogen receptor X}} |
| + | | list3 = {{Navbox|subgroup | ||
| + | | groupstyle = text-align:center | ||
| + | | groupwidth = 6em; | ||
| − | | group1 = | + | | group1 = Agonists |
| list1 = | | list1 = | ||
| − | * | + | * [[Alfatradiol|17α-Estradiol (alfatradiol)]] |
| + | * [[Estradiol]] | ||
| + | |||
| + | | group2 = Antagonists | ||
| + | | list2 = | ||
| − | + | }} | |
| − | | | + | | group4 = {{abbrlink|G<sub>q</sub>-mER|Gq-coupled membrane estrogen receptor}} |
| − | | | + | | list4 = {{Navbox|subgroup |
| − | | groupstyle = text-align:center; | + | | groupstyle = text-align:center |
| + | | groupwidth = 6em; | ||
| − | | group1 = | + | | group1 = Agonists |
| list1 = | | list1 = | ||
| − | * [[ | + | * [[Estradiol]] |
| − | * [[ | + | * [[STX (drug)|STX]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | | group2 = Antagonists | |
| − | + | | list2 = | |
| − | * [[ | + | * [[Fulvestrant|Fulvestrant (ICI-182780)]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | }} | |
| + | --> | ||
| − | | below = | + | | below = |
| + | ;See also | ||
| + | : [[Template:Receptor modulators|Receptor/signaling modulators]] | ||
| + | : [[Template:Estrogens and antiestrogens|Estrogens and antiestrogens]] | ||
| + | : [[Template:Androgen receptor modulators|Androgen receptor modulators]] | ||
| + | : [[Template:Progesterone receptor modulators|Progesterone receptor modulators]] | ||
| + | : [[List of steroidal estrogens|List of estrogens]] | ||
| − | }}<noinclude> | + | }} |
| + | <noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
[[Category:Estrogens]] | [[Category:Estrogens]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 18:59, 30 July 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Estrogen receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Estrogen receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Estrogen receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.